New weapon tested in fight against Tough-to-Treat cancers
NCT ID NCT06819735
Summary
This study is testing a new drug called DT-7012 for people with advanced solid tumors that have spread or returned after other treatments. The main goals are to find a safe dose and see if the drug, given alone or with an immunotherapy, can help control the cancer. It is an early-stage trial for adults whose cancer has progressed and who have no other curative options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabrini Health Limited
RECRUITINGMalvern, Victoria, 3144, Australia
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Hôpitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67200, France
-
Institut Bergonié
NOT_YET_RECRUITINGBordeaux, 33076, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
-
Macquarie University Clinical Trial Unit
RECRUITINGNorth Ryde, New South Wales, 2109, Australia
-
One Clinical Research Pty Ltd
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Peninsula & South Eastern Haematology & Oncology Group
RECRUITINGFrankston, Victoria, 3199, Australia
Conditions
Explore the condition pages connected to this study.